- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
BAXDELA - 300mg - 10
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01MA23 | B | Delafloxacin - 300mg | 11119 | 16321/1 | BAXDELA | 300mg | 10 | Injectable concentrate for solution | Infusion | Droguerie de l'Union | Patheon Italia SpA, Italy under licensed from Melinta Therapeutics, Inc, Illinois, USA | Italy | 78,349,010 L.L | 10.71 | E1 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |